137 related articles for article (PubMed ID: 38457386)
21. Single treatment of low-risk basal cell carcinomas with pulsed dye laser-mediated photodynamic therapy (PDL-PDT) compared with photodynamic therapy (PDT): A controlled, investigator-blinded, intra-individual prospective study.
Čarija A; Puizina-Ivić N; Vuković D; Mirić Kovačević L; Čapkun V
Photodiagnosis Photodyn Ther; 2016 Dec; 16():60-65. PubMed ID: 27516420
[TBL] [Abstract][Full Text] [Related]
22. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
[TBL] [Abstract][Full Text] [Related]
23. Assessment of therapeutic efficacy in seven cases of basal cell carcinoma in the ear and nose region treated with new surgical excision and immediate photodynamic therapy.
Yang P; He B; Zhong J; Zhao X; Bu Z
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103904. PubMed ID: 37984528
[TBL] [Abstract][Full Text] [Related]
24. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage.
Soler AM; Warloe T; Berner A; Giercksky KE
Br J Dermatol; 2001 Sep; 145(3):467-71. PubMed ID: 11531838
[TBL] [Abstract][Full Text] [Related]
25. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma.
van Delft LCJ; Nelemans PJ; Kessels JPHM; Kreukels H; Roozeboom MH; de Rooij MJM; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Dermatology; 2022; 238(6):1044-1049. PubMed ID: 35598594
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D
Br J Dermatol; 2005 Apr; 152(4):765-72. PubMed ID: 15840111
[TBL] [Abstract][Full Text] [Related]
28. A new photodynamic therapy protocol for nodular basal cell carcinoma treatment: Effectiveness and long-term follow-up.
Salvio AG; Veneziano DB; Moriyama LT; Inada NM; Grecco C; Kurachi C; Bagnato VS
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102668. PubMed ID: 34863948
[TBL] [Abstract][Full Text] [Related]
29. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
[TBL] [Abstract][Full Text] [Related]
30. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
[TBL] [Abstract][Full Text] [Related]
31. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
Collier NJ; Haylett AK; Wong TH; Morton CA; Ibbotson SH; McKenna KE; Mallipeddi R; Moseley H; Seukeran D; Ward KA; Mohd Mustapa MF; Exton LS; Green AC; Rhodes LE
Br J Dermatol; 2018 Dec; 179(6):1277-1296. PubMed ID: 29889302
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
[TBL] [Abstract][Full Text] [Related]
33. Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma.
Smucler R; Vlk M
Lasers Surg Med; 2008 Feb; 40(2):153-8. PubMed ID: 18306163
[TBL] [Abstract][Full Text] [Related]
34. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
[TBL] [Abstract][Full Text] [Related]
35. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
Szeimies RM
Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
[TBL] [Abstract][Full Text] [Related]
36. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study.
Christensen E; Mørk C; Skogvoll E
Br J Dermatol; 2012 Jun; 166(6):1342-8. PubMed ID: 22309486
[TBL] [Abstract][Full Text] [Related]
37. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.
Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P
Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873
[TBL] [Abstract][Full Text] [Related]
38. Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study.
van Delft LCJ; Nelemans PJ; Jansen MHE; Arits AHMM; Roozeboom MH; Hamid MA; Mosterd K; Kelleners-Smeets NWJ
J Am Acad Dermatol; 2019 Apr; 80(4):1022-1028. PubMed ID: 30582993
[TBL] [Abstract][Full Text] [Related]
39. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.
Christensen E; Skogvoll E; Viset T; Warloe T; Sundstrøm S
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):58-66. PubMed ID: 18803580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
